VanEck Associates’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$335K Buy
+785
New +$322K ﹤0.01% 1267
2025
Q1
– Sell
-1,754
Closed -$526K – 1399
2024
Q4
$526K Sell
1,754
-80
-4% -$28K ﹤0.01% 1128
2024
Q3
$752K Buy
+1,834
New +$671K ﹤0.01% 1035
2024
Q1
– Sell
-2,585
Closed -$700K – 1389
2023
Q4
$700K Sell
2,585
-438
-14% -$108K ﹤0.01% 1005
2023
Q3
$744K Buy
+3,023
New +$827K ﹤0.01% 970
2021
Q3
– Sell
-3,563
Closed -$737K – 1306
2021
Q2
$737K Buy
3,563
+141
+4% +$28.7K ﹤0.01% 853
2021
Q1
$644K Buy
+3,422
New +$603K ﹤0.01% 814

Other funds holding HCA

VanEck Associates's HCA Position: Q3 2026 in Review

VanEck Associates opened a new position in HCA Healthcare (HCA) in Q3 2026: 785 shares worth $335K. The stake represents ﹤0.01% of the portfolio and ranks #1267 among its holdings. This is a return to the name: VanEck Associates previously reported a position in HCA as recently as Q4 2024.

VanEck Associates first reported a position in HCA in Q1 2021 and has held it in 7 quarters since. The position peaked at $752K in Q3 2024. 1,350 funds tracked by Wall St. Rank hold HCA as of Q3 2026.

  • VanEck Associates held 785 shares of HCA Healthcare worth $335K as of Q3 2026.
  • HCA Healthcare was a new VanEck Associates position in Q3 2026.
  • HCA Healthcare made up ﹤0.01% of VanEck Associates's portfolio in Q3 2026, its #1267 holding.
  • VanEck Associates first reported a position in HCA Healthcare in Q1 2021 and has held it in 7 quarters since.
  • VanEck Associates's HCA Healthcare position peaked at $752K in Q3 2024.
  • 1,350 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2026.

Based on VanEck Associates's 13F filing for Q3 2026, filed 13 Nov 2026.